ARENA PHARMACEUTICALS $7.98

down -0.02


17/5/2013 07:17 PM  |  NASDAQ : ARNA  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
4/1/2013 HOFFMAN ROBERT SVP, Finance and CFO -71,250 $8.21 -78.45%
4/1/2013 HOFFMAN ROBERT SVP, Finance and CFO 71,250 $1.81 364.08%
10/1/2012 HOFFMAN ROBERT SVP, Finance and CFO 50,000 $1.48 1,478.42%
10/1/2012 HOFFMAN ROBERT SVP, Finance and CFO -50,000 $8.32 -93.66%
7/5/2012 HOFFMAN ROBERT SVP, Finance and CFO -10,000 $11.00 -78.35%
7/3/2012 SPECTOR STEVEN W EVP, General Counsel & Sec 22,300 $4.01 56.33%
7/3/2012 SPECTOR STEVEN W EVP, General Counsel & Sec -22,300 $10.05 -36.03%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec 16,666 $6.00 27.97%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec 22,699 $4.01 29.77%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec 30,000 $3.25 30.32%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec 45,000 $1.49 34.90%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec -95,000 $9.96 -54.61%
7/2/2012 SPECTOR STEVEN W EVP, General Counsel & Sec -39,365 $10.04 -49.86%
3/29/2012 Bielasz Jennifer Kathleen Sr.Dir. of Acct. & Cont. (PAO) -4,550 $3.01 -48.66%
3/29/2012 Bielasz Jennifer Kathleen Sr.Dir. of Acct. & Cont. (PAO) -6,250 $3.04 -40.06%
3/29/2012 Bielasz Jennifer Kathleen Sr.Dir. of Acct. & Cont. (PAO) 6,250 $1.49 66.84%
1/6/2012 HOFFMAN ROBERT VP, Finance and CFO -150 $1.63 -1.22%
1/6/2012 HOFFMAN ROBERT VP, Finance and CFO 150 $1.64 1.24%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ARNA), click here.
Marketplace
Trading Center